A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients
- Registry ID
- EUCTR2016-004952-30
- Source registry
- EUCTR
- Phase
- PHASE3
- Sponsor
- Eisai Co, Ltd.
- Last update
- 2026-08-16
Conditions
- Lennox-Gastaut Syndrome (LSG)
Summary
To evaluate that the efficacy of E2080 in percent change in
tonic-atonic seizure frequency in participants with LGS relative to placebo.
View on source registry